<?xml version="1.0" encoding="UTF-8"?>
<ref id="B285-pharmaceuticals-12-00147">
 <label>285.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huang</surname>
    <given-names>C.-G.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>L.-A.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.-C.</given-names>
   </name>
   <name>
    <surname>Hsiao</surname>
    <given-names>M.-J.</given-names>
   </name>
   <name>
    <surname>Horng</surname>
    <given-names>J.-T.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>R.-L.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.-H.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y.-C.</given-names>
   </name>
   <name>
    <surname>Tsao</surname>
    <given-names>K.-C.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>M.-C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A pilot study on primary cultures of human respiratory tract epithelial cells to predict patientsâ€™ responses to H7N9 infection</article-title>
  <source>Oncotarget</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>14492</fpage>
  <lpage>14508</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.24537</pub-id>
  <pub-id pub-id-type="pmid">29581859</pub-id>
 </element-citation>
</ref>
